GPI pulse™ - Global Pricing Innovations Indication-Level Treatment Costs is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. GPI pulse™ is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. This powerful platform is designed to be used as part of GPI’s comprehensive solution for pricing and market access strategy, but can also be leveraged to rapidly extract customised sets of analysis-ready data. In addition to the drug-level price and reimbursement data, GPI pulse™ also offers indication-level treatment costs for a more granular view. This additional layer allows for standardised comparison of cost to treat a patient (per day/moth/annum) across markets and by specific indication. This indication-level data requires further calculations that consider the posology. For this reason, regulatory label approval data are incorporated to provide an accurate picture of the treatment costs per patient in each market. Use cases: - Understand the difference in cost to treat a patient by indication in a particular market - Compare the cost to treat a patient in different markets of interest - Standardised comparisons of the cost to treat a patient with different therapies - Visualise historical price evolution GPI continually invest in technology, taxonomy, and quality assurance, to ensure our data is the gold-standard in terms of accuracy, granularity, and timeliness. GPI pulse™ supports the full spectrum of biopharma clients, from top tier pharma to clinical stage biotech. The analytics tools within GPI pulse™ are built specifically with pricing, market access, and commercial strategy teams in mind. FREE DATA SAMPLES AVAILABLE: - Pricing - Cost of Treatment - Reimbursement and HTA